Peptide opioid antagonist separates peripheral and central opioid antitransit effects

Journal of Pharmacology and Experimental Therapeutics

Volumn 243, Issue 2, 1987, Pages 492-500

  Shook, J E ^a   Pelton, J T ^a   Hruby, V J ^a   Burks, T F ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; DYNORPHIN DERIVATIVE; ENKEPHALIN DERIVATIVE; KAPPA OPIATE RECEPTOR; MORPHICEPTIN[3 (N METHYLPHENYLALANINE) 4 DEXTRO PROLINAMIDE]; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; OPIATE RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; CENTRAL NERVOUS SYSTEM; GASTROINTESTINAL TRANSIT; MOUSE; NONHUMAN;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESIA; ANIMAL; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDORPHINS; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; GASTROINTESTINAL MOTILITY; MALE; MICE; MICE, INBRED ICR; MORPHINE; PYRROLIDINES; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023481952     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)